Encompass Health Corporation (EHC) Stock Analysis
Healthcare · Medical Care Facilities
Hold if already holding. Not a fresh buy at $99.84, but acceptable to hold if already in. Reasons: Negative momentum; Below 200-MA, MA slope -1.5%/30d (confirmed downtrend).
Encompass Health Corporation is the nation's largest owner and operator of inpatient rehabilitation hospitals, operating 173 facilities across 39 states and Puerto Rico, with concentrations in Florida and Texas. The company generated $5.9 billion in net operating revenues in... Read more
Hold if already holding. Not a fresh buy at $99.84, but acceptable to hold if already in. Reasons: Negative momentum; Below 200-MA, MA slope -1.5%/30d (confirmed downtrend). Chart setup: No clear chart pattern; technical signals are mixed. Maintain position. Not compelling to add more. Score 6.1/10, moderate confidence.
Passes 7/9 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, earnings proximity 49d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and death cross (50MA < 200MA). Suitability: moderate.
About Encompass Health Corporation
About Encompass Health Corporation
Encompass Health Corporation operated 173 inpatient rehabilitation hospitals across 39 states and Puerto Rico at December 31, 2025, generating total net operating revenues of $5.9 billion — up from $5.4 billion in 2024 — and treating 263,299 patients through discharge. Concentrations in Florida and Texas reflect the company's strategy of expanding in high-growth demographic markets. The company has opened or acquired 78 new hospitals and increased licensed bed count by approximately 72% since 2012, and employed over 42,000 individuals at year-end.
Encompass Health earns revenue primarily through Medicare reimbursement under the inpatient rehabilitation facility prospective payment system, alongside Medicare Advantage, Medicaid, and commercial payors. Substantially all (92%) of patients are admitted from acute-care hospitals following physician referrals — a structure that makes the company dependent on relationships with referring hospitals and health systems. More than a third of hospitals operate as joint ventures with acute-care systems, creating referral alignment. The company competes against rehabilitation units within acute-care hospitals, privately held post-acute care providers, and one publicly traded company operating 38 inpatient rehabilitation hospitals. The target patient demographic is concentrated in Medicare beneficiaries aged 65 and older, where the population of age 75 and over is expected to grow at approximately 4% per year through 2030, providing long-term demand growth.
Show full overview
Medicare reimbursement risk is the dominant regulatory exposure. The 10-K identifies restrictive coverage determinations by Medicare Advantage plans during pre-authorization as a material threat to revenues, while also noting that changes in payment system re-basing or the introduction of value-based models could reduce revenues if not offset by demonstrated outcome superiority. The company has pursued improvement in MA payments by demonstrating higher discharge-to-community rates and lower lengths of stay versus alternative care sites. If CMS re-bases the IRF payment system or reduces rates, Encompass Health's revenues and operating margins could be materially affected.
See also: Healthcare · Medical Care Facilities
From Encompass Health Corporation's most recent 10-K filing, extracted June 10, 2026.
Recent developments
updated 2026-06-17Recent Developments — Encompass Health Corporation
Latest news
- NEWS Encompass Health (EHC) Q1 Earnings Report Preview: What To Look For - Yahoo Finance — Yahoo Finance neutral
- NEWS Encompass Health (EHC) Q1 Earnings Report Preview: What To Look For - StockStory — StockStory neutral
- NEWS Encompass Health (EHC) Q1 Earnings Report Preview: What To Look For - TradingView — TradingView neutral
- NEWS Is Encompass Health Corp (EHC) a Bargain After 3.3% Drop? GF Val - GuruFocus — GuruFocus neutral
- NEWS How Investors May Respond To Encompass Health (EHC) Q1 Earnings Beat, Buybacks, And Tennessee Expansion - Yahoo Finance — Yahoo Finance positive
Generated 2026-06-17T08:31:51Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- MEDIUMGeographicFlorida and Texas10-K Item 1: 'We operate hospitals in 39 states and Puerto Rico, with concentrations in Florida and Texas.'
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 floor-breaker
Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $99.84, but acceptable to hold if already in. Reasons: Negative momentum; Below 200-MA, MA slope -1.5%/30d (confirmed downtrend). Chart setup: No clear chart pattern; technical signals are mixed. Maintain position. Not compelling to add more. Target $122.23 (+22.4%), stop $95.37 (−4.7%), A.R:R 3.6:1. Score 6.1/10, moderate confidence.
Take-profit target: $122.23 (+22.4% upside). Target $122.23 (+22.4%), stop $95.37 (−4.7%), A.R:R 3.6:1. Stop-loss: $95.37.
Negative momentum; Below 200-MA, MA slope -1.5%/30d (confirmed downtrend).
Encompass Health Corporation trades at a P/E of 17.0 (forward 15.2). TrendMatrix value score: 8.1/10. Verdict: Hold.
17 analysts cover EHC with a consensus score of 4.4/5. Average price target: $141.
What does Encompass Health Corporation do?Encompass Health Corporation is the nation's largest owner and operator of inpatient rehabilitation hospitals,...
Encompass Health Corporation is the nation's largest owner and operator of inpatient rehabilitation hospitals, operating 173 facilities across 39 states and Puerto Rico, with concentrations in Florida and Texas. The company generated $5.9 billion in net operating revenues in 2025, earning revenue primarily from Medicare, Medicare Advantage, Medicaid, and commercial payors, with 92% of patients admitted from acute-care hospitals following physician referrals.